187 related articles for article (PubMed ID: 32650019)
21. Re: COVID-19 in Solid Organ Transplant Recipients: Initial Report from the US Epicenter.
Goldfarb DA
J Urol; 2020 Sep; 204(3):607. PubMed ID: 32586172
[No Abstract] [Full Text] [Related]
22. Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan.
Tu WJ; Cao J; Yu L; Hu X; Liu Q
Intensive Care Med; 2020 Jun; 46(6):1117-1120. PubMed ID: 32253448
[No Abstract] [Full Text] [Related]
23. New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws.
Bennardo F; Buffone C; Giudice A
Oral Oncol; 2020 Jul; 106():104659. PubMed ID: 32209313
[No Abstract] [Full Text] [Related]
24. Pharmacist-driven education for solid organ transplant recipients in the COVID-19 era.
Fan A; Kamath M
Clin Transplant; 2020 Aug; 34(8):e14013. PubMed ID: 32578893
[No Abstract] [Full Text] [Related]
25. Vascular microthrombosis associated with increased interleukin-6. A severe acute respiratory distress syndrome in COVID-19 patients treated with tocilizumab.
Mohebbi N; Abedini A; Lashgari R; Razavi F; Varahram M; Kiani A
Adv Respir Med; 2020; 88(5):468-469. PubMed ID: 33169824
[No Abstract] [Full Text] [Related]
26. Tocilizumab in COVID-19: Beware the risk of intestinal perforation.
Vikse J; Henry BM
Int J Antimicrob Agents; 2020 Jul; 56(1):106009. PubMed ID: 32389721
[No Abstract] [Full Text] [Related]
27. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
28. Cytokine Storm Drugs Move from CAR T to COVID-19.
Cancer Discov; 2020 Jul; 10(7):OF8. PubMed ID: 32371479
[TBL] [Abstract][Full Text] [Related]
29. Lessons from the Italian COVID-19 frontline.
Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
[No Abstract] [Full Text] [Related]
30. Is a "Cytokine Storm" Relevant to COVID-19?
Sinha P; Matthay MA; Calfee CS
JAMA Intern Med; 2020 Sep; 180(9):1152-1154. PubMed ID: 32602883
[No Abstract] [Full Text] [Related]
31. [Severe acute respiratory syndrome coronavirus 2 infection in renal transplant recipients: A case report].
Li QY; Cheng Q; Zhao ZL; Dai NN; Zeng L; Zhu L; Guo W; Li C; Wang JH; Li S; Ge QG; Shen N
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):780-784. PubMed ID: 32773818
[TBL] [Abstract][Full Text] [Related]
32. Early tocilizumab treatment could improve survival among COVID-19 patients.
Campins L; Boixeda R; Perez-Cordon L; Aranega R; Lopera C; Force L
Clin Exp Rheumatol; 2020; 38(3):578. PubMed ID: 32456769
[No Abstract] [Full Text] [Related]
33. COVID-19 Lockdown: Impact on Liver Transplant Recipients- A Single Centre Survey.
Jothimani D; Daniel H; Danielraj S; Ramachandran H; Rela M
J Assoc Physicians India; 2020 Aug; 68(8):96. PubMed ID: 32738853
[No Abstract] [Full Text] [Related]
34. Re: Lan Zhu, Nianqiao Gong, Bin Liu, et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Eur Urol 2020;77:748-54.
Bansal A; Kumar A
Eur Urol; 2020 Oct; 78(4):e158. PubMed ID: 32660746
[No Abstract] [Full Text] [Related]
35. COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.
Mihai C; Dobrota R; Schröder M; Garaiman A; Jordan S; Becker MO; Maurer B; Distler O
Ann Rheum Dis; 2020 May; 79(5):668-669. PubMed ID: 32241792
[No Abstract] [Full Text] [Related]
36. Emergency management for kidney transplantation in the epidemic period of coronavirus disease 2019.
Fang C; Wang L; Nie M; Liu Y; Huang J; Xie X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):495-500. PubMed ID: 32879096
[TBL] [Abstract][Full Text] [Related]
37. First, Do No Harm: Caution Against Use of Tocilizumab in COVID-19.
Mastroianni F
Chest; 2020 Nov; 158(5):2233. PubMed ID: 33160536
[No Abstract] [Full Text] [Related]
38. Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
Kemmner S; Guba MO; Schönermarck U; Stangl M; Fischereder M
Kidney Int; 2020 Aug; 98(2):507-508. PubMed ID: 32505466
[No Abstract] [Full Text] [Related]
39. Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome.
Faqihi F; Alharthy A; Karakitsos D
J Formos Med Assoc; 2020 Dec; 119(12):1888-1889. PubMed ID: 32680687
[No Abstract] [Full Text] [Related]
40. Early experience with COVID-19 in kidney transplantation.
Coates PT; Wong G; Drueke T; Rovin B; Ronco P;
Kidney Int; 2020 Jun; 97(6):1074-1075. PubMed ID: 32354635
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
